A detailed history of Benedict Financial Advisors Inc transactions in Novartis Ag stock. As of the latest transaction made, Benedict Financial Advisors Inc holds 16,861 shares of NVS stock, worth $1.75 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
16,861
Previous 17,192 1.93%
Holding current value
$1.75 Million
Previous $1.83 Million 5.96%
% of portfolio
0.46%
Previous 0.47%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$106.13 - $120.89 $35,129 - $40,014
-331 Reduced 1.93%
16,861 $1.94 Million
Q2 2024

Jul 30, 2024

BUY
$92.57 - $107.37 $16,570 - $19,219
179 Added 1.05%
17,192 $1.83 Million
Q1 2024

Apr 25, 2024

SELL
$95.27 - $108.47 $13,623 - $15,511
-143 Reduced 0.83%
17,013 $1.65 Million
Q4 2023

Jan 29, 2024

SELL
$92.27 - $101.54 $13,286 - $14,621
-144 Reduced 0.83%
17,156 $1.73 Million
Q3 2023

Oct 18, 2023

SELL
$94.73 - $105.13 $21,408 - $23,759
-226 Reduced 1.29%
17,300 $1.76 Million
Q2 2023

Aug 10, 2023

SELL
$92.52 - $104.91 $6,568 - $7,448
-71 Reduced 0.4%
17,526 $1.77 Million
Q1 2023

May 11, 2023

BUY
$80.03 - $92.81 $15,925 - $18,469
199 Added 1.14%
17,597 $1.62 Million
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $3,324 - $4,070
44 Added 0.25%
17,398 $1.58 Million
Q3 2022

Nov 07, 2022

SELL
$74.61 - $87.26 $11,862 - $13,874
-159 Reduced 0.91%
17,354 $1.32 Million
Q2 2022

Jul 28, 2022

BUY
$80.52 - $93.75 $43,319 - $50,437
538 Added 3.17%
17,513 $1.48 Million
Q1 2022

May 03, 2022

BUY
$80.11 - $90.62 $37,571 - $42,500
469 Added 2.84%
16,975 $1.49 Million
Q4 2021

Feb 09, 2022

BUY
$79.7 - $88.13 $22,873 - $25,293
287 Added 1.77%
16,506 $1.44 Million
Q3 2021

Oct 29, 2021

BUY
$81.78 - $95.14 $63,052 - $73,352
771 Added 4.99%
16,219 $1.33 Million
Q2 2021

Aug 05, 2021

BUY
$85.24 - $94.15 $3,324 - $3,671
39 Added 0.25%
15,448 $1.41 Million
Q1 2021

May 10, 2021

BUY
$83.5 - $98.47 $7,348 - $8,665
88 Added 0.57%
15,409 $1.32 Million
Q4 2020

Feb 02, 2021

SELL
$78.07 - $94.43 $2,732 - $3,305
-35 Reduced 0.23%
15,321 $1.45 Million
Q2 2020

Jul 23, 2020

SELL
$80.93 - $91.1 $890 - $1,002
-11 Reduced 0.07%
15,356 $1.34 Million
Q1 2020

Apr 21, 2020

SELL
$70.67 - $99.01 $4,946 - $6,930
-70 Reduced 0.45%
15,367 $1.27 Million
Q4 2019

Feb 04, 2020

SELL
$84.35 - $95.37 $9,953 - $11,253
-118 Reduced 0.76%
15,437 $1.46 Million
Q3 2019

Nov 04, 2019

SELL
$85.54 - $94.26 $16,765 - $18,474
-196 Reduced 1.24%
15,555 $1.35 Million
Q2 2019

Aug 01, 2019

BUY
$75.4 - $92.8 $11,310 - $13,920
150 Added 0.96%
15,751 $1.44 Million
Q1 2019

May 01, 2019

BUY
$75.32 - $86.15 $2,410 - $2,756
32 Added 0.21%
15,601 $1.5 Million
Q4 2018

Jan 30, 2019

SELL
$73.66 - $82.02 $6,629 - $7,381
-90 Reduced 0.57%
15,569 $1.34 Million
Q3 2018

Nov 05, 2018

BUY
$66.94 - $77.43 $3,347 - $3,871
50 Added 0.32%
15,659 $1.35 Million
Q2 2018

Jul 24, 2018

BUY
$64.91 - $73.36 $24,665 - $27,876
380 Added 2.5%
15,609 $1.18 Million
Q1 2018

May 02, 2018

SELL
$70.39 - $84.15 $21,257 - $25,413
-302 Reduced 1.94%
15,229 $1.23 Million
Q4 2017

Feb 05, 2018

SELL
$72.33 - $77.64 $2,097 - $2,251
-29 Reduced 0.19%
15,531 $1.3 Million
Q3 2017

Oct 26, 2017

BUY
$74.14 - $77.27 $1.15 Million - $1.2 Million
15,560
15,560 $1.34 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Benedict Financial Advisors Inc Portfolio

Follow Benedict Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benedict Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benedict Financial Advisors Inc with notifications on news.